These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 11881607
1. Accutane risk management program strengthened. FDA Consum; 2002; 36(1):8. PubMed ID: 11881607 [No Abstract] [Full Text] [Related]
2. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program. Brinker A, Kornegay C, Nourjah P. Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377 [Abstract] [Full Text] [Related]
3. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin). Doshi A. Seton Hall Law Rev; 2007 May; 37(2):625-60. PubMed ID: 17294569 [No Abstract] [Full Text] [Related]
4. Accutane-exposed pregnancies--California, 1999. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2000 Jan 21; 49(2):28-31. PubMed ID: 10680601 [Abstract] [Full Text] [Related]
6. A pox on your practice. iPLEDGE program scars dermatologists. Ortolon K. Tex Med; 2006 May 21; 102(5):29-31. PubMed ID: 17115578 [No Abstract] [Full Text] [Related]
7. Safe use of acne drug. FDA Consum; 2005 May 21; 39(6):4. PubMed ID: 16669109 [No Abstract] [Full Text] [Related]
8. A risk management program aimed at preventing fetal exposure to isotretinoin: retrospective cohort study. Cheetham TC, Wagner RA, Chiu G, Day JM, Yoshinaga MA, Wong L. J Am Acad Dermatol; 2006 Sep 21; 55(3):442-8. PubMed ID: 16908350 [Abstract] [Full Text] [Related]
9. Update on isotretinoin (Accutane) for acne. Med Lett Drugs Ther; 1983 Nov 25; 25(649):105-6. PubMed ID: 6227800 [No Abstract] [Full Text] [Related]
10. Ethical and legal aspects of teratogenic medications: the case of isotretinoin. Moskop JC, Smith ML, De Ville K. J Clin Ethics; 1997 Nov 25; 8(3):264-78. PubMed ID: 9436085 [No Abstract] [Full Text] [Related]
11. Coping with the isotretinoin registry. Baldwin HE. Dermatol Ther; 2006 Nov 25; 19(4):241-50. PubMed ID: 17005000 [Abstract] [Full Text] [Related]
12. Accutane (isotretinoin) revisited: severe birth defects from acne therapy. Hansen RC. Ariz Med; 1985 Jun 25; 42(6):363-5. PubMed ID: 3161486 [No Abstract] [Full Text] [Related]
13. FDA ponders approaches to curbing adverse effects of drug used against cystic acne. Marwick C. JAMA; 1988 Jun 10; 259(22):3225. PubMed ID: 2967382 [No Abstract] [Full Text] [Related]
14. Acne and accutane. Burton CS, Eyre RW, Callaway JL. N C Med J; 1984 Aug 10; 45(8):513. PubMed ID: 6236375 [No Abstract] [Full Text] [Related]
16. Adolescents, acne, and the side-effects of Accutane. Novotny J. Pediatr Nurs; 1989 Aug 10; 15(3):247-8. PubMed ID: 2525246 [Abstract] [Full Text] [Related]
17. Isotretinoin prescribing: finding a balance between benefit and risk. Stern RS. Pharmacoepidemiol Drug Saf; 2005 Sep 10; 14(9):611-3. PubMed ID: 16134100 [No Abstract] [Full Text] [Related]
18. What is the best approach to reducing birth defects associated with isotretinoin? Abroms L, Maibach E, Lyon-Daniel K, Feldman SR. PLoS Med; 2006 Nov 10; 3(11):e483. PubMed ID: 17121451 [Abstract] [Full Text] [Related]
19. [Teratogenicity of isotretinoin]. Orfanos CE. Hautarzt; 1984 Oct 10; 35(10):503-5. PubMed ID: 6238920 [No Abstract] [Full Text] [Related]
20. Acne drug controversy ignites turf battle over prescribing. Thomas P. Med World News; 1988 Jun 13; 29(11):46-7. PubMed ID: 10313737 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]